Safeguard Scientifics to Realize Additional Proceeds from Eli Lilly and Company’s Acquisition of Avid Radiopharmaceuticals, Inc.

WAYNE, Pa.--(BUSINESS WIRE)--Safeguard Scientifics, Inc. (NYSE: SFE), a holding company that builds value in growth-stage life sciences and technology companies, today announced that it expects to receive an additional $5.6 million in proceeds from Eli Lilly and Company’s (NYSE: LLY) acquisition of former partner company Avid Radiopharmaceuticals, Inc., which took place in December 2010.

MORE ON THIS TOPIC